RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. (IST:RTALB)

IST:RTALB Revenue

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. had revenue of 85.98M TRY in the quarter ending September 30, 2026, with 65.08% growth. This brings the company's total for the last twelve months to 316.21M, up 29.94% year-over-year. In the year 2025, RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. had annual revenue of 239.56M with 15.41% growth. That makes RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. the 39,215th largest company in the world by revenue and 542nd in Turkey.

• Revenue (ttm): 316.21M
• Revenue Growth: +29.94%
• P/S Ratio: 3.16
• Revenue / Employee: 4.33M
• Employees: 77
• Market Cap: 1.00B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Turkey 241.51M 99.5%
• Foreign 1.14M 0.5%

Fiscal year ended Dec 31, 2025 See the full IST:RTALB breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	239.56M	31.98M	15.41%
Dec 31, 2024	207.58M	69.07M	49.87%
Dec 31, 2023	138.51M	-52.79M	-27.59%
Dec 31, 2022	191.30M	-193.04M	-50.23%
Dec 31, 2021	384.34M	153.90M	66.78%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error